Search
Returning search results with filters:
Remove filter for
Category: Drugs
Remove filter for
Last updated: May 2020
Remove filter for
Last updated: 2020
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
Recall class
Displaying 1 - 15 of 15 items.
Importation of US-Labelled Rocuronium Bromide Injection Due to Shortage of Canadian-labelled Rocuronium
AlertHealth professional risk communication | 2020-05-25
Cisatracurium Omega Multi-Dose (Cisatracurium Besylate Injection): Temporary change of ferrule (metal seal) colour to maintain continued supply in Canada
AlertHealth professional risk communication | 2020-05-25
Importation of US-Labelled Rocuronium Bromide Injection distributed by Avir Pharma Inc. Due to Shortage of Canadian-labelled Rocuronium
AlertHealth professional risk communication | 2020-05-25
Splash Corporation Maxi-Peel Exfoliant product recall (2020-05-22)
RecallHealth product recall | 2020-05-22
Duavive (2020-05-20)
RecallHealth product recall | 2020-05-20
Importation of Fresenius Propoven 2% due to Shortage of Canadian Labelled Propofol Injection 1% Products
AlertHealth professional risk communication | 2020-05-19
Importation of Spanish-Labelled Salbutamol Aldo-Union inhalers due to Shortage of Canadian-Labelled Salbutamol
AlertHealth professional risk communication | 2020-05-19
Penicillin G Sodium for Injection (2020-05-16)
RecallHealth product recall | 2020-05-16
Important Safety Information - Importation of Teva UK-labelled Salamol CFC-Free (Salbutamol Sulfate) Inhaler due to Shortage
AlertHealth professional risk communication | 2020-05-13
Glucovision (Citrate) (2020-05-11)
RecallHealth product recall | 2020-05-11
Tepadina (2020-05-08)
RecallHealth product recall | 2020-05-08
Ratio-Cotridine (2020-05-08)
RecallHealth product recall | 2020-05-08
Importation of US-Labelled Ketamine Hydrochloride for Injection due to Potential Shortage of Canadian-labelled Ketamine
AlertHealth professional risk communication | 2020-05-06
Axid (nizatidine) drug recalled due to presence of NDMA
AlertPublic advisory | 2020-05-01